Nuveen Churchill Direct Lending Corp. Announces Third Quarter 2025 Results
Reports Third Quarter Net Investment Income of $0.43 per Share Declares Fourth Quarter Regular Distribution of $0.45 per Share NEW YORK–(BUSINESS WIRE)–Nuveen... Read more.
Sovato Closes Series B to Advance the World’s First and Only Remote Robotic Surgery & Procedure Platform
The funding will enable Sovato to scale its first-of-its-kind platform, empowering healthcare organizations to safely extend surgical expertise anywhere. SANTA BARBARA,... Read more.
Tidepool Collaborates With ŌURA to Advance Inclusive Diabetes Research Through Wearables
Collaboration to build landmark dataset in diabetes PALO ALTO, Calif.–(BUSINESS WIRE)–Tidepool, a 501(c)(3) nonprofit leader in diabetes software, today... Read more.
Piersica Unveils PIRION™, a Breakthrough Polymer Technology Engineered for the Battery Industry
TALLAHASSEE, Fla.–(BUSINESS WIRE)–#AdvancedMaterials—Piersica, Inc., a leader in next-generation battery innovation, today announced the launch... Read more.
Dubai Holding and Palantir launch Aither: A joint venture to lead AI transformation
Aither, Palantir’s first joint venture in the UAE, will drive AI-powered transformation across Dubai’s public and private sectors As the first enterprise AI... Read more.
Global Payments Reports Third Quarter 2025 Results
Third quarter 2025 GAAP diluted earnings per share (EPS) of $2.64 and adjusted EPS of $3.26, an increase of 11% constant currency Third quarter 2025 GAAP revenue... Read more.
Uber Announces Results for Third Quarter 2025
Trips grew 22% year-over-year and Gross Bookings grew 21% year-over-year Income from operations of $1.1 billion; Adjusted EBITDA of $2.3 billion, up 33% year-over-year... Read more.
PJT Partners Inc. Reports Record Third Quarter and Nine Months 2025 Results
Third Quarter Overview Record Third Quarter Revenues, Pretax Income and EPS Revenues of $447 million, an increase of 37% from a year ago GAAP Pretax Income of $91... Read more.
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
Strategic financing to advance development of sac-TMT while Merck continues to progress its broad and expansive pipeline RAHWAY, N.J.–(BUSINESS WIRE)–Merck... Read more.
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the company, through a subsidiary... Read more.